Immunological techniques
Agglutinations,
Complement fixation,
Immune diffusion,
Immunoelectrophoresis,
RIA and ELISA,
Western blotting
Strength of Antigen-Antibody Interactions
• The noncovalent interactions that form the basis of antigen-antibody
(Ag-Ab) binding include (Figure 6-1).
• hydrogen bonds,
• ionic bonds,
• hydrophobic interactions, and
• van der Waals interactions
• These interactions are individually weak (compared with a covalent
bond), a large number of such interactions are required to form a
strong Ag-Ab interaction.
• Furthermore, each of these noncovalent interactions operates over a
very short distance, generally about 1X 10-7
mm (1 angstrom, Å);
consequently, a strong Ag- Ab interaction depends on a very close fit
between the antigen and antibody.
• Such fits require a high degree of complementarity between antigen
and antibody, a requirement that underlies the exquisite specificity
that characterizes antigen-antibody interactions.
The interaction between an
antibody and an antigen depends
on four types of noncovalent forces:
(1) hydrogen bonds, in which a
hydrogen atom is shared between
two electronegative atoms;
(2) ionic bonds between oppositely
charged residues;
(3) hydrophobic interactions, in
which water forces hydrophobic
groups together; and
(4) van der Waals interactions
between the outer electron clouds
of two or more atoms.
In an aqueous environment,
noncovalent interactions are
extremely weak and depend upon
close complementarity of the
shapes of antibody and antigen.
Antigen
An antigen is a foreign substance that enters your
body.
bacteria,
viruses,
fungi,
allergens,
Venom
Pollen grains and
other various toxins.
Antibodies are Immunoglobulins
• They are protective
glycoproteins produced by your
immune system.
• They attach to antigens (foreign
substances) — such as bacteria,
fungi, viruses and toxins and
remove them from your body.
• Antibodies are produced by B cells
specialized white blood cells.
• When an antigen comes into contact with a B
cell, it causes the B cell to divide and clone.
• These cloned B cells — or plasma cells — release
millions of antibodies into your bloodstream
and lymph system.
There are five types of antibodies with distinct functions
• IgM –
– Found in your blood and lymph system
– first line of defense against infections
– play a large role in immune regulation.
• IgG –
– Makes upto 70% to 75% of all immunoglobulins
– found mainly in blood and tissue fluids.
– protect the body from viral and bacterial infections.
• IgE-
– Found mainly in skin, lungs and mucus membranes,
– cause the mast cells -a type of white blood cell to release histamine into
the bloodstream.
– causing allergic reactions.
• IgD-
– IgD supports B cell maturation and activation.
• IgA-
– Found in saliva, tears, mucus, breast milk and intestinal fluid,
– protects against ingested and inhaled pathogens.
So
• The binding of Ag-Ab
interaction is due to high
degree of complementarity
between antigen and
antibody, offering the
exquisite specificity that is
their characteristic.
Antigen-Antibody Interactions
The basis of antigen-antibody (Ag-Ab) binding
are the weak noncovalent interactions
hydrogen bonds,
 ionic bonds,
 hydrophobic interactions,
 van der Waals interactions
• The exquisite specificity of antigen-antibody
interactions
has led
• to the development of a variety of immunologic
assays,
which can be used
• to detect the presence of either antibody or
antigen.
immunotechnique assays
• Immunoassays have played vital roles in
diagnosing diseases, monitoring the level of the
humoral immune response, and identifying
molecules of biological or medical interest.
• These assays differ in their;
–speed and sensitivity
–strictly qualitative and quantitative.
1. Agglutination techniques
Agglutination, which refers to the clumping of
particles together, is an antigen-antibody
reaction that occurs when an antigen (i.e., a
molecule capable of triggering the adaptive
immune response) is mixed with its
corresponding antibody at a suitable pH and
temperature
In agglutination reactions, serial dilutions of
the antibody solution are made and a
constant amount of particulate antigen is
added to serially diluted antibody solutions.
After several hours of incubation at 37°C,
clumping is recorded by visual inspection
Agglutination
• In active agglutination, direct agglutination of
particulate antigen with specific antibody
occurs.
• Whole pathogens are used as a source of
antigen.
• It measures the antibody level produced by a
host infected with that pathogen.
• The binding of antibodies to surface antigens
on the bacteria results in visible clumps
Active agglutination can be of following types:
Slide/Tile agglutination:
• performed on a slide.
• Used for identification of bacterial types
• A suspension of unknown antigen on the slide is allowed to interact
with a drop of standardized antiserum is added or vice versa.
• A positive reaction results in formation of visible clumps. E.g. Widal
test,
Tube agglutination:
• It is performed in tube
• It is a standard quantitative technique for determination of antibody
titer.
• In this method serum is diluted in a series of tubes and standard
antigen suspensions (specific for the suspected disease) are added
to it.
• After incubation, antigen-antibody reaction is indicated by visible
clumps of agglutination.
Examples
• Agglutination reactions for blood grouping
• The 4 blood groups are A, B, AB and O.
• Each of these will be either Rh-positive or Rh-
negative.
• The blood groups refer to the presence on human red
blood cells of certain antigens, the blood group
factors.
• One very important group of factors present on the
red blood cells is the ABO system.
• The ABO group of a person depends on whether
his/her red blood cells contain one, both, or neither of
the 2 blood group antigens A and B.
• There are, therefore, 4 main ABO groups: A, B, AB and
O.
• Antibodies (agglutinins) for the antigens A and
B exist in the plasma and these are termed
anti-A and anti-B.
• The corresponding antigen and antibody are
never found in the same individual since,
when mixed, they form antigen-antibody
complexes, effectively agglutinating the blood.
• One end of a slide is labelled Anti-A, and the other
Anti-B. A drop of Anti-A test serum is added to the
end marked Anti-A, and a drop of Anti-B serum is
added to the end marked Anti-B.
Testing for ABO Group – Procedure
One drop of blood is added to each end
of the slide, and mixed well, using
separate wooden sticks.
The results are read directly from the slide. The subject
is blood group A if agglutination occurred with the
Anti-A test serum; group B if agglutination occurred
with the Anti-B test serum; group AB if agglutination
occurred with both test serums, and O if there was no
agglutination in either case.
In the sample to the right, we conclude the subject
has type A blood.
• When transfusing blood, it is important to
remember that the donor's blood must not
contain red blood cells that the recipient's
antibodies can agglutinate.
• Theoretically, then, individuals belonging to
blood group O are universal donors, while
those of blood group AB are universal
recipients.
Antiglobulin (Coombs) test:
• This’ test was devised by Coombs, Mourant, and
Race for detection of incomplete anti-Rh antibodies
that do not agglutinate Rh+ erythrocytes in saline.
• When serum containing incomplete anti-Rh
antibodies is mixed with Rh+ erythrocytes in saline,
incomplete antibody antiglobulin coats the surface
of erythrocytes but does not cause any
agglutination.
• When such erythrocytes are treated with
antiglobulin or Coombs serum (rabbit antiserum
against human gamma globulin), then the cells are
agglutinated.
• Coombs test can be direct as well as indirect.
Hemagglutination uses erythrocytes as the biological carriers
of bacterial antigens, and purified polysaccharides or proteins
for determining the presence of corresponding antibodies in a
specimen.
Complement fixation
The complement fixation test is
an immunological medical test that can be
used to detect the presence of either
specific antibody or specific antigen in a
patient's serum, based on
whether complement fixation occurs.
• The complement fixation test is a blood test
that can determine the presence of antigen-
specific antibodies by incubating patient
serum with antigen and complement.
• This assay takes advantage of the requirement
for complement to be activated by the
combination of antigen–antibody complexes
Steps of the method
•serum proteins react with antigen-antibody complexes.
•If this reaction occurs on a cell surface, it will result in the formation of
trans-membrane pores leading to the destruction of the cell.
•The basic steps of a complement fixation test are as follows:
1.A serum sample is taken.
2.It is then heated at about 56 °C to remove the complement proteins
already present in the sample.
3.The serum is then adsorbed with washed sheep RBC. It prevents
interference in the test by anti-RBC antibodies which are cross-
reactive.
4.Then the antigen and complement are added to the sample.
5.It is then subjected to incubation at a temperature of 37 °C for 30
minutes. It provides conditions and time for the formation of the Ag-
Ab complex.
6.And the indicator system is then added and the sample is observed
for change due to occurrence or non-occurrence of hemolysis.
7.If the color changes to pink then the test is negative
3. Immunodiffusion Reactions
• Antibody and soluble antigen
interacting in aqueous solution form a
lattice that eventually develops into a
visible precipitate.
• Antibodies that aggregate soluble
antigens are called precipitins.
• Although formation of the soluble Ag-
Ab complex occurs within minutes,
formation of the visible precipitate
occurs more slowly and often takes a
day or two to reach completion
Examples
– radial immunodiffusion - the Mancini method
– double immunodiffusion- the Ouchterlony double
diffusion method
• a semisolid medium such as agarose or agar.
Ab
As equivalence is reached, a visible line of
precipitation, a precipitin line, forms
Radial immunodiffusion
• An antigen sample is placed in a well and allowed to
diffuse into agar containing a suitable dilution of an
antiserum.
• As the antigen diffuses into the agar, the region of
equivalence is established and a ring of precipitation,
a precipitin ring, forms around the well
• The area of the precipitin ring is proportional
to the concentration of antigen.
• By comparing the area of the precipitin ring
with a standard curve the concentration of
the antigen sample can be determined.
4. Immunoelectrophoresis
Combines Electrophoresis and Double
Immunodiffusion
• In immunoelectrophoresis, the
antigen mixture is first
electrophorezed to separate
its components by charge.
• Troughs are then cut into the
agar gel parallel to the
direction of the electric field,
and antiserum is added to the
troughs.
• Antibody and antigen then
diffuse toward each other and
produce lines of precipitation
where they meet in
appropriate proportions
Application
• clinical laboratories to detect the
presence or absence of proteins -
antigens in the serum
• a patient produces abnormally low
amounts of one or more isotypes,
characteristic of certain
immunodeficiency diseases to diagnose
if a patient overproduces some serum
protein, such as albumin,
immunoglobulin, or transferrin.
Multiple myeloma
• serum from patients shows a heavy
distorted arc caused by the large
amount of myeloma protein-
monoclonal Ig
• A related quantitative technique,
rocket electrophoresis, does
permit measurement of antigen
levels.
• In rocket electrophoresis, a
negatively charged antigen is
electrophoresed in a gel
containing antibody.
• The precipitate formed between
antigen and antibody has the
shape of a rocket, the height of
which is proportional to the
concentration of antigen in the
well.
RIA – radioimmunoassay
Radioimmunoassay (RIA) is a competitive assay
technique in which the reagent, the antibody
(Ab), is used in a limited amount as compared
with the amount of analyte antigen (Ag).
To perform a RIA, it is essential to have a
radioactively labeled antigen (Ag ),
∗ which is
used as the tracer.
The principle and procedure :
•competitive binding of radiolabeled antigen and unlabeled antigen
to a high-affinity antibody.
•The labeled antigen is mixed with antibody at a concentration that
saturates the antigen-binding sites of the antibody.
•Then test samples of unlabeled antigen of unknown concentration
are added in progressively larger amounts.
•The antibody does not distinguish labeled from unlabeled antigen,
so the two kinds of antigen compete for available binding sites on
the antibody.
•As the concentration of unlabeled antigen increases, more labeled
antigen will be displaced from the binding sites.
•The decrease in the amount of radiolabeled antigen bound to
specific antibody in the presence of the test sample is the measure
of the amount of antigen present in the test sample.
•The antigen is generally labeled with a gamma-emitting isotope
such as 125
I, beta-emitting isotopes such as tritium 3
H as labels.
• A binding curve is then be generated which
allows the amount of antigen in the patient’s
serum to be derived.
• That means as the concentration of unlabeled
antigen is increased, more of it binds to the
antibody, displacing the labeled variant.
• The bound antigens are then separated from
the unbound ones, and the radioactivity of the
free antigens remaining in the supernatant is
measured.
• Counting radioactivity in the precipitates
allows the determination of the amount of
radiolabeled antigen precipitated with the
antibody.
• A standard curve is constructed by plotting the
percentage of antibody-bound radiolabeled
antigen against known concentrations of a
standardized unlabeled antigen, and
• the concentrations of antigen in patient
samples are extrapolated from that curve.
Radioimmunoassay (RIA) Applications
• It was first used for the detection of peptide
hormones.
• Detection of different viral antigens
• Detection of many hormones and drugs
• Detection of Hepatitis B surface antigens
• Detection of mycotoxins
• Detection of the early stage of cancer
4. Enzyme-Linked Immunosorbent Assay (ELISA)
• An enzyme conjugated with an antibody
reacts with a colorless substrate to generate a
colored reaction product.
• A number of enzymes have been employed for
ELISA, including
– alkaline phosphatase,
– horseradish peroxidase, and
– beta-galactosidase
Types of ELISA include
– Indirect ELISA
– Sandwich ELISA
– Competitive ELISA
INDIRECT ELISA
• Antibody can be detected or quantitatively determined with an
indirect ELISA
• Serum or some other sample containing primary antibody (Ab1) is
added to an antigen-coated microtiter well and allowed to react with
the antigen attached to the well.
• After any free Ab1 is washed away, the presence of antibody bound to
the antigen is detected by adding an enzyme-conjugated secondary
anti-isotype antibody (Ab2), which binds to the primary antibody.
• Any free Ab2 then is washed away, and a substrate for the enzyme is
added.
• The amount of colored reaction product that forms is measured by
specialized spectrophotometric ELISA plate readers, which can
measure the absorbance of all of the wells of a 96-well plate in
seconds.
• Indirect ELISA is the method of choice to detect the presence of serum
antibodies against human immunodeficiency virus (HIV), the causative
agent of AIDS.
Sandwish ELISA
• Antigen can be detected or measured by a sandwich ELISA
• In this technique, the antibody is immobilized on a microtiter
well.
• A sample containing antigen is added and allowed to react with
the immobilized antibody.
• After the well is washed, a second enzyme-linked antibody
specific for a different epitope on the antigen is added and
allowed to react with the bound antigen.
• After any free second antibody is removed by washing, substrate
is added, and the colored reaction product is measured.
Competitive ELISA
• Antibody is first incubated in solution with a sample
containing antigen.
• The antigen-antibody mixture is then added to an antigen
coated microtiter well.
• The more antigen present in the sample, the less free antibody
will be available to bind to the antigen-coated well.
• Addition of an enzyme-conjugated secondary antibody (Ab2)
specific for the isotype of the primary antibody can be used to
determine the amount of primary antibody bound to the well
as in an indirect ELISA.
5. Western Blotting
• Identification of a specific protein in a complex
mixture of proteins can be accomplished by a
technique known as Western blotting
• A protein mixture is electrophoretically separated
on an SDS-polyacrylamide gel (SDS-PAGE) as bands
• The protein bands are transferred to a nylon
membrane by electrophoresis and
• the individual protein bands are identified by
flooding the nitrocellulose membrane with
enzyme linked polyclonal or monoclonal antibody
specific for the protein of interest.
• After binding a chromogenic substrate that
produces a highly colored and insoluble product
causes the appearance of a colored band at the site
of the target antigen.
An electron micrograph showing a cell
with magnetic beads attached to its
surface via antibodies.
6. Immunofluorescence
• In 1944, Albert Coons showed that antibodies could be
labeled with molecules that have the property of
fluorescence.
• Fluorescent molecules absorb light of one wavelength
(excitation) and emit light of another wavelength (emission).
• If antibody molecules are tagged with a fluorescent dye, or
fluorochrome, immune complexes containing these
fluorescently labeled antibodies (FA) can be detected by
colored light emission when excited by light of the
appropriate wavelength.
• Antibody molecules bound to antigens in cells or tissue
sections can similarly be visualized.
• The emitted light can be viewed with a fluorescence
microscope, having a UV light source.
Dyes used
• Fluorescein, an organic dye absorbs blue light
(490 nm) and emits an intense yellow-green
fluorescence (517 nm).
• Rhodamine, absorbs in the yellow-green
range (515 nm) and emits a deep red
fluorescence (546 nm).
• Phycoerythrin a brilliant emitter of red
fluorescence,
In direct staining, the primary antibody is directly conjugated with
fluorescein;
In indirect staining, the primary antibody is unlabeled and is
detected with an additional fluorochrome-labeled reagent
• Indirect immunofluorescence staining has two
advantages over direct staining.
• First, the primary antibody does not need to be
conjugated with a fluorochrome.
• Because the supply of primary antibody is often a
limiting factor,
• indirect methods avoid the loss of antibody that usually
occurs during the conjugation reaction.
• Second, the sensitivity of staining increases because
multiple molecules of the fluorochrome reagent bind to
each primary antibody molecule,
• increases the amount of light emitted at the location of
each primary antibody molecule.
In this micrograph, antibody molecules
bearing heavy chains are detected by indirect
staining of cells with rhodamine-conjugated
second antibody.
7. Immunoelectron Microscopy
• specific intracellular tissue components can be visualized by
immunoelectron microscopy
• In this technique,
– an electron-dense label is conjugated to the Fc portion of a specific
antibody for direct staining or
– conjugated to an anti-immunoglobulin reagent for indirect staining.
• A number of electron-dense labels have been employed,
Ferritin and colloidal gold.
• The electron-dense label absorbs electrons, it can be visualized
with the electron microscope (Transmission Electron
Mciroscope) as small black dots.
• In the case of immunogold labeling, different antibodies can be
conjugated with gold particles of different sizes, allowing
identification of several antigens within a cell by the different
sizes of the electron-dense gold particles attached to the
antibodies (Figure 6-16).
The electron-dense label absorbs
electrons, it can be visualized with
the electron microscope
(Transmission Electron Mciroscope)
as small black dots.
8. Flow Cytometry – Fluorescence activated cell sorter
(FACS)
• Gives quantitative data
• The flow cytometer uses a laser beam and light
detector to count single intact cells in suspension
• Every time a cell passes the laser beam, light is
deflected from the detector, and this interruption of
the laser signal is recorded.
• Those cells having a fluorescently tagged antibody
bound to their cell surface antigens are excited by the
laser and emit light that is recorded by a second
detector system located at a right angle to the laser
beam.
FITC- fluorescein isothiocyanate
PE-phycoerythrin
lower left-hand panel not
to have reacted with
either antibody anti-A or
anti-B.
upper left panel
reacted with anti-
B but not anti-A,
those in the lower
right panel reacted
with anti-A but not
anti-B
upper right panel
contains cells that
react with both
anti-A
and anti-B
Four subpopulations
can be distinguished:
• Leukemia is the unchecked proliferation of an
abnormal clone of hematopoietic cells
• The diagnosis of leukemia is made on the basis of
two findings.
– One is the detection of abnormal cells in the
bloodstream, and the other is observation of abnormal
cells in the bone marrow.
• An abnormal cell displays surface immunoglobulin
would be assigned to the B-cell lineage and its
maturational stage would be that of a mature B cell.
• On the other hand, a cell that had cytoplasmic
heavy chains, but no surface immunoglobulin,
would be a B-lineage leukemic cell but at the
maturational stage of a pre-B cell.
• Immunophenotyping uses flow cytometry and
monoclonal antibodies
• The availability of monoclonal antibodies specific
for each of the scores of antigens found on
various types and subtypes of hematopoietic
cells has made it possible to identify patterns of
antigen expression that are typical of
– cell lineages,
– maturational stages, and
– a number of different types of leukemia
Application
• Most cancer centers are equipped with flow cytometers
that are capable of performing and interpreting the
multiparameter analyses necessary to provide useful
profiles of surface markers on tumor cell populations.
• Flow cytometric determination of immuno-phenotypes
allows:
– Confirmation of diagnosis
– Diagnosis when no clear judgment can be made based on
morphology or patterns of cytochemical staining
– Identification of aberrant antigen profiles that can help
identify the return of leukemia during remission
– Improved prediction of the course of the disease
SUMMARY
• Antigen-antibody interactions depend on four types of
noncovalent interactions: hydrogen bonds, ionic bonds,
hydrophobic interactions, and van der Waals interactions.
• The affinity constant, which can be determined by Scatchard
analysis, provides a quantitative measure of the strength of
the interaction between an epitope of the antigen and a single
binding site of an antibody.
• The avidity reflects the overall strength of the interactions
between a multivalent antibody molecule and a multivalent
antigen molecule at multiple sites.
• The interaction of a soluble antigen and precipitating
antibody in a liquid or gel medium forms an Ag-Ab precipitate.
• Electrophoresis can be combined with precipitation in gels in a
technique called immunoelectrophoresis.
• The interaction between a particulate antigen and agglutinating
antibody (agglutinin) produces visible clumping, or agglutination
that forms the basis of simple, rapid, and sensitive immunoassays.
• The enzyme-linked immunosorbent assay (ELISA) depends on an
enzyme-substrate reaction that generates a colored reaction
product.
• ELISA assays that employ chemiluminescence are the most
sensitive immunoassays available.
• In Western blotting, a protein mixture is separated by
electrophoresis; then the protein bands are electrophoretically
transferred onto nitrocellulose and identified with labeled antibody
or labeled antigen.
• Fluorescence microscopy using antibodies labeled with fluorescent
molecules can be used to visualize antigen on or within cells.
• Flow cytometry provides an unusually powerful technology for the
quantitative analysis and sorting of cell populations labeled with
one or more fluorescent antibodies.
Hemeagglutination
• Agglutination reactions are routinely performed to type
red blood cells
• In typing for the ABO antigens, RBCs are mixed on a
slide with antisera to the A or B blood-group antigens.
• If the antigen is present on the cells, they agglutinate,
forming a visible clump on the slide.
• Determination of which antigens are present on donor
and recipient RBCs is the basis for matching blood
types for transfusions.
1. Cross-Reactivity
• In some cases antibody elicited by one antigen can
cross-react with an unrelated antigen.
• Cross-reactivity occurs if two different antigens
share an identical or very similar epitope
• Cross-reactivity is often observed among
polysaccharide antigens that contain similar
oligosaccharide residues.
Example:
 The ABO blood-group antigens, for example, are
glycoproteins expressed on red blood cells.
 Cross-reactivity is often observed among
polysaccharide antigens that contain similar
oligosaccharide residues.
• Type A individual has anti-B antibodies;
• Type B individual has anti-A;
• Type O individual has anti-A and anti-B
• Antibodies are produced to these antigens
• The antibodies are induced not by exposure to red blood
cell antigens but by exposure to cross-reacting microbial
antigens present on common intestinal bacteria.
• These microbial antigens induce the formation of
antibodies in individuals lacking the similar blood-group
antigens on their red blood cells
• These blood-group antibodies, although elicited by
microbial antigens, will cross-react with similar
oligosaccharides on foreign red blood cells,
• This provides the basis for blood typing tests and
accounting for the necessity of compatible blood types
during blood transfusions.
Thank you

class 19 unit4 immunological techniques.pptx

  • 1.
    Immunological techniques Agglutinations, Complement fixation, Immunediffusion, Immunoelectrophoresis, RIA and ELISA, Western blotting
  • 2.
    Strength of Antigen-AntibodyInteractions • The noncovalent interactions that form the basis of antigen-antibody (Ag-Ab) binding include (Figure 6-1). • hydrogen bonds, • ionic bonds, • hydrophobic interactions, and • van der Waals interactions • These interactions are individually weak (compared with a covalent bond), a large number of such interactions are required to form a strong Ag-Ab interaction. • Furthermore, each of these noncovalent interactions operates over a very short distance, generally about 1X 10-7 mm (1 angstrom, Å); consequently, a strong Ag- Ab interaction depends on a very close fit between the antigen and antibody. • Such fits require a high degree of complementarity between antigen and antibody, a requirement that underlies the exquisite specificity that characterizes antigen-antibody interactions.
  • 3.
    The interaction betweenan antibody and an antigen depends on four types of noncovalent forces: (1) hydrogen bonds, in which a hydrogen atom is shared between two electronegative atoms; (2) ionic bonds between oppositely charged residues; (3) hydrophobic interactions, in which water forces hydrophobic groups together; and (4) van der Waals interactions between the outer electron clouds of two or more atoms. In an aqueous environment, noncovalent interactions are extremely weak and depend upon close complementarity of the shapes of antibody and antigen.
  • 4.
    Antigen An antigen isa foreign substance that enters your body. bacteria, viruses, fungi, allergens, Venom Pollen grains and other various toxins.
  • 5.
    Antibodies are Immunoglobulins •They are protective glycoproteins produced by your immune system. • They attach to antigens (foreign substances) — such as bacteria, fungi, viruses and toxins and remove them from your body.
  • 6.
    • Antibodies areproduced by B cells specialized white blood cells. • When an antigen comes into contact with a B cell, it causes the B cell to divide and clone. • These cloned B cells — or plasma cells — release millions of antibodies into your bloodstream and lymph system.
  • 7.
    There are fivetypes of antibodies with distinct functions • IgM – – Found in your blood and lymph system – first line of defense against infections – play a large role in immune regulation. • IgG – – Makes upto 70% to 75% of all immunoglobulins – found mainly in blood and tissue fluids. – protect the body from viral and bacterial infections. • IgE- – Found mainly in skin, lungs and mucus membranes, – cause the mast cells -a type of white blood cell to release histamine into the bloodstream. – causing allergic reactions. • IgD- – IgD supports B cell maturation and activation. • IgA- – Found in saliva, tears, mucus, breast milk and intestinal fluid, – protects against ingested and inhaled pathogens.
  • 10.
    So • The bindingof Ag-Ab interaction is due to high degree of complementarity between antigen and antibody, offering the exquisite specificity that is their characteristic. Antigen-Antibody Interactions The basis of antigen-antibody (Ag-Ab) binding are the weak noncovalent interactions hydrogen bonds,  ionic bonds,  hydrophobic interactions,  van der Waals interactions
  • 11.
    • The exquisitespecificity of antigen-antibody interactions has led • to the development of a variety of immunologic assays, which can be used • to detect the presence of either antibody or antigen. immunotechnique assays
  • 12.
    • Immunoassays haveplayed vital roles in diagnosing diseases, monitoring the level of the humoral immune response, and identifying molecules of biological or medical interest. • These assays differ in their; –speed and sensitivity –strictly qualitative and quantitative.
  • 14.
    1. Agglutination techniques Agglutination,which refers to the clumping of particles together, is an antigen-antibody reaction that occurs when an antigen (i.e., a molecule capable of triggering the adaptive immune response) is mixed with its corresponding antibody at a suitable pH and temperature
  • 15.
    In agglutination reactions,serial dilutions of the antibody solution are made and a constant amount of particulate antigen is added to serially diluted antibody solutions. After several hours of incubation at 37°C, clumping is recorded by visual inspection
  • 16.
    Agglutination • In activeagglutination, direct agglutination of particulate antigen with specific antibody occurs. • Whole pathogens are used as a source of antigen. • It measures the antibody level produced by a host infected with that pathogen. • The binding of antibodies to surface antigens on the bacteria results in visible clumps
  • 17.
    Active agglutination canbe of following types: Slide/Tile agglutination: • performed on a slide. • Used for identification of bacterial types • A suspension of unknown antigen on the slide is allowed to interact with a drop of standardized antiserum is added or vice versa. • A positive reaction results in formation of visible clumps. E.g. Widal test, Tube agglutination: • It is performed in tube • It is a standard quantitative technique for determination of antibody titer. • In this method serum is diluted in a series of tubes and standard antigen suspensions (specific for the suspected disease) are added to it. • After incubation, antigen-antibody reaction is indicated by visible clumps of agglutination.
  • 18.
    Examples • Agglutination reactionsfor blood grouping • The 4 blood groups are A, B, AB and O. • Each of these will be either Rh-positive or Rh- negative.
  • 19.
    • The bloodgroups refer to the presence on human red blood cells of certain antigens, the blood group factors. • One very important group of factors present on the red blood cells is the ABO system. • The ABO group of a person depends on whether his/her red blood cells contain one, both, or neither of the 2 blood group antigens A and B. • There are, therefore, 4 main ABO groups: A, B, AB and O.
  • 20.
    • Antibodies (agglutinins)for the antigens A and B exist in the plasma and these are termed anti-A and anti-B. • The corresponding antigen and antibody are never found in the same individual since, when mixed, they form antigen-antibody complexes, effectively agglutinating the blood.
  • 21.
    • One endof a slide is labelled Anti-A, and the other Anti-B. A drop of Anti-A test serum is added to the end marked Anti-A, and a drop of Anti-B serum is added to the end marked Anti-B. Testing for ABO Group – Procedure One drop of blood is added to each end of the slide, and mixed well, using separate wooden sticks. The results are read directly from the slide. The subject is blood group A if agglutination occurred with the Anti-A test serum; group B if agglutination occurred with the Anti-B test serum; group AB if agglutination occurred with both test serums, and O if there was no agglutination in either case. In the sample to the right, we conclude the subject has type A blood.
  • 22.
    • When transfusingblood, it is important to remember that the donor's blood must not contain red blood cells that the recipient's antibodies can agglutinate. • Theoretically, then, individuals belonging to blood group O are universal donors, while those of blood group AB are universal recipients.
  • 23.
    Antiglobulin (Coombs) test: •This’ test was devised by Coombs, Mourant, and Race for detection of incomplete anti-Rh antibodies that do not agglutinate Rh+ erythrocytes in saline. • When serum containing incomplete anti-Rh antibodies is mixed with Rh+ erythrocytes in saline, incomplete antibody antiglobulin coats the surface of erythrocytes but does not cause any agglutination. • When such erythrocytes are treated with antiglobulin or Coombs serum (rabbit antiserum against human gamma globulin), then the cells are agglutinated. • Coombs test can be direct as well as indirect.
  • 24.
    Hemagglutination uses erythrocytesas the biological carriers of bacterial antigens, and purified polysaccharides or proteins for determining the presence of corresponding antibodies in a specimen.
  • 26.
    Complement fixation The complementfixation test is an immunological medical test that can be used to detect the presence of either specific antibody or specific antigen in a patient's serum, based on whether complement fixation occurs.
  • 27.
    • The complementfixation test is a blood test that can determine the presence of antigen- specific antibodies by incubating patient serum with antigen and complement. • This assay takes advantage of the requirement for complement to be activated by the combination of antigen–antibody complexes
  • 28.
    Steps of themethod •serum proteins react with antigen-antibody complexes. •If this reaction occurs on a cell surface, it will result in the formation of trans-membrane pores leading to the destruction of the cell. •The basic steps of a complement fixation test are as follows: 1.A serum sample is taken. 2.It is then heated at about 56 °C to remove the complement proteins already present in the sample. 3.The serum is then adsorbed with washed sheep RBC. It prevents interference in the test by anti-RBC antibodies which are cross- reactive. 4.Then the antigen and complement are added to the sample. 5.It is then subjected to incubation at a temperature of 37 °C for 30 minutes. It provides conditions and time for the formation of the Ag- Ab complex. 6.And the indicator system is then added and the sample is observed for change due to occurrence or non-occurrence of hemolysis. 7.If the color changes to pink then the test is negative
  • 30.
  • 31.
    • Antibody andsoluble antigen interacting in aqueous solution form a lattice that eventually develops into a visible precipitate. • Antibodies that aggregate soluble antigens are called precipitins. • Although formation of the soluble Ag- Ab complex occurs within minutes, formation of the visible precipitate occurs more slowly and often takes a day or two to reach completion
  • 33.
    Examples – radial immunodiffusion- the Mancini method – double immunodiffusion- the Ouchterlony double diffusion method • a semisolid medium such as agarose or agar.
  • 35.
    Ab As equivalence isreached, a visible line of precipitation, a precipitin line, forms
  • 36.
    Radial immunodiffusion • Anantigen sample is placed in a well and allowed to diffuse into agar containing a suitable dilution of an antiserum. • As the antigen diffuses into the agar, the region of equivalence is established and a ring of precipitation, a precipitin ring, forms around the well
  • 39.
    • The areaof the precipitin ring is proportional to the concentration of antigen. • By comparing the area of the precipitin ring with a standard curve the concentration of the antigen sample can be determined.
  • 40.
  • 41.
    • In immunoelectrophoresis,the antigen mixture is first electrophorezed to separate its components by charge. • Troughs are then cut into the agar gel parallel to the direction of the electric field, and antiserum is added to the troughs. • Antibody and antigen then diffuse toward each other and produce lines of precipitation where they meet in appropriate proportions
  • 42.
    Application • clinical laboratoriesto detect the presence or absence of proteins - antigens in the serum • a patient produces abnormally low amounts of one or more isotypes, characteristic of certain immunodeficiency diseases to diagnose if a patient overproduces some serum protein, such as albumin, immunoglobulin, or transferrin. Multiple myeloma • serum from patients shows a heavy distorted arc caused by the large amount of myeloma protein- monoclonal Ig
  • 43.
    • A relatedquantitative technique, rocket electrophoresis, does permit measurement of antigen levels. • In rocket electrophoresis, a negatively charged antigen is electrophoresed in a gel containing antibody. • The precipitate formed between antigen and antibody has the shape of a rocket, the height of which is proportional to the concentration of antigen in the well.
  • 44.
    RIA – radioimmunoassay Radioimmunoassay(RIA) is a competitive assay technique in which the reagent, the antibody (Ab), is used in a limited amount as compared with the amount of analyte antigen (Ag). To perform a RIA, it is essential to have a radioactively labeled antigen (Ag ), ∗ which is used as the tracer.
  • 45.
    The principle andprocedure : •competitive binding of radiolabeled antigen and unlabeled antigen to a high-affinity antibody. •The labeled antigen is mixed with antibody at a concentration that saturates the antigen-binding sites of the antibody. •Then test samples of unlabeled antigen of unknown concentration are added in progressively larger amounts. •The antibody does not distinguish labeled from unlabeled antigen, so the two kinds of antigen compete for available binding sites on the antibody. •As the concentration of unlabeled antigen increases, more labeled antigen will be displaced from the binding sites. •The decrease in the amount of radiolabeled antigen bound to specific antibody in the presence of the test sample is the measure of the amount of antigen present in the test sample. •The antigen is generally labeled with a gamma-emitting isotope such as 125 I, beta-emitting isotopes such as tritium 3 H as labels.
  • 47.
    • A bindingcurve is then be generated which allows the amount of antigen in the patient’s serum to be derived. • That means as the concentration of unlabeled antigen is increased, more of it binds to the antibody, displacing the labeled variant. • The bound antigens are then separated from the unbound ones, and the radioactivity of the free antigens remaining in the supernatant is measured.
  • 48.
    • Counting radioactivityin the precipitates allows the determination of the amount of radiolabeled antigen precipitated with the antibody. • A standard curve is constructed by plotting the percentage of antibody-bound radiolabeled antigen against known concentrations of a standardized unlabeled antigen, and • the concentrations of antigen in patient samples are extrapolated from that curve.
  • 50.
    Radioimmunoassay (RIA) Applications •It was first used for the detection of peptide hormones. • Detection of different viral antigens • Detection of many hormones and drugs • Detection of Hepatitis B surface antigens • Detection of mycotoxins • Detection of the early stage of cancer
  • 51.
    4. Enzyme-Linked ImmunosorbentAssay (ELISA) • An enzyme conjugated with an antibody reacts with a colorless substrate to generate a colored reaction product. • A number of enzymes have been employed for ELISA, including – alkaline phosphatase, – horseradish peroxidase, and – beta-galactosidase
  • 53.
    Types of ELISAinclude – Indirect ELISA – Sandwich ELISA – Competitive ELISA
  • 55.
    INDIRECT ELISA • Antibodycan be detected or quantitatively determined with an indirect ELISA • Serum or some other sample containing primary antibody (Ab1) is added to an antigen-coated microtiter well and allowed to react with the antigen attached to the well. • After any free Ab1 is washed away, the presence of antibody bound to the antigen is detected by adding an enzyme-conjugated secondary anti-isotype antibody (Ab2), which binds to the primary antibody. • Any free Ab2 then is washed away, and a substrate for the enzyme is added. • The amount of colored reaction product that forms is measured by specialized spectrophotometric ELISA plate readers, which can measure the absorbance of all of the wells of a 96-well plate in seconds. • Indirect ELISA is the method of choice to detect the presence of serum antibodies against human immunodeficiency virus (HIV), the causative agent of AIDS.
  • 57.
    Sandwish ELISA • Antigencan be detected or measured by a sandwich ELISA • In this technique, the antibody is immobilized on a microtiter well. • A sample containing antigen is added and allowed to react with the immobilized antibody. • After the well is washed, a second enzyme-linked antibody specific for a different epitope on the antigen is added and allowed to react with the bound antigen. • After any free second antibody is removed by washing, substrate is added, and the colored reaction product is measured.
  • 58.
    Competitive ELISA • Antibodyis first incubated in solution with a sample containing antigen. • The antigen-antibody mixture is then added to an antigen coated microtiter well. • The more antigen present in the sample, the less free antibody will be available to bind to the antigen-coated well. • Addition of an enzyme-conjugated secondary antibody (Ab2) specific for the isotype of the primary antibody can be used to determine the amount of primary antibody bound to the well as in an indirect ELISA.
  • 60.
    5. Western Blotting •Identification of a specific protein in a complex mixture of proteins can be accomplished by a technique known as Western blotting
  • 61.
    • A proteinmixture is electrophoretically separated on an SDS-polyacrylamide gel (SDS-PAGE) as bands • The protein bands are transferred to a nylon membrane by electrophoresis and • the individual protein bands are identified by flooding the nitrocellulose membrane with enzyme linked polyclonal or monoclonal antibody specific for the protein of interest. • After binding a chromogenic substrate that produces a highly colored and insoluble product causes the appearance of a colored band at the site of the target antigen.
  • 67.
    An electron micrographshowing a cell with magnetic beads attached to its surface via antibodies.
  • 68.
    6. Immunofluorescence • In1944, Albert Coons showed that antibodies could be labeled with molecules that have the property of fluorescence. • Fluorescent molecules absorb light of one wavelength (excitation) and emit light of another wavelength (emission). • If antibody molecules are tagged with a fluorescent dye, or fluorochrome, immune complexes containing these fluorescently labeled antibodies (FA) can be detected by colored light emission when excited by light of the appropriate wavelength. • Antibody molecules bound to antigens in cells or tissue sections can similarly be visualized. • The emitted light can be viewed with a fluorescence microscope, having a UV light source.
  • 69.
    Dyes used • Fluorescein,an organic dye absorbs blue light (490 nm) and emits an intense yellow-green fluorescence (517 nm). • Rhodamine, absorbs in the yellow-green range (515 nm) and emits a deep red fluorescence (546 nm). • Phycoerythrin a brilliant emitter of red fluorescence,
  • 70.
    In direct staining,the primary antibody is directly conjugated with fluorescein; In indirect staining, the primary antibody is unlabeled and is detected with an additional fluorochrome-labeled reagent
  • 71.
    • Indirect immunofluorescencestaining has two advantages over direct staining. • First, the primary antibody does not need to be conjugated with a fluorochrome. • Because the supply of primary antibody is often a limiting factor, • indirect methods avoid the loss of antibody that usually occurs during the conjugation reaction. • Second, the sensitivity of staining increases because multiple molecules of the fluorochrome reagent bind to each primary antibody molecule, • increases the amount of light emitted at the location of each primary antibody molecule.
  • 72.
    In this micrograph,antibody molecules bearing heavy chains are detected by indirect staining of cells with rhodamine-conjugated second antibody.
  • 73.
    7. Immunoelectron Microscopy •specific intracellular tissue components can be visualized by immunoelectron microscopy • In this technique, – an electron-dense label is conjugated to the Fc portion of a specific antibody for direct staining or – conjugated to an anti-immunoglobulin reagent for indirect staining. • A number of electron-dense labels have been employed, Ferritin and colloidal gold. • The electron-dense label absorbs electrons, it can be visualized with the electron microscope (Transmission Electron Mciroscope) as small black dots. • In the case of immunogold labeling, different antibodies can be conjugated with gold particles of different sizes, allowing identification of several antigens within a cell by the different sizes of the electron-dense gold particles attached to the antibodies (Figure 6-16).
  • 74.
    The electron-dense labelabsorbs electrons, it can be visualized with the electron microscope (Transmission Electron Mciroscope) as small black dots.
  • 75.
    8. Flow Cytometry– Fluorescence activated cell sorter (FACS) • Gives quantitative data • The flow cytometer uses a laser beam and light detector to count single intact cells in suspension • Every time a cell passes the laser beam, light is deflected from the detector, and this interruption of the laser signal is recorded. • Those cells having a fluorescently tagged antibody bound to their cell surface antigens are excited by the laser and emit light that is recorded by a second detector system located at a right angle to the laser beam.
  • 76.
  • 77.
    lower left-hand panelnot to have reacted with either antibody anti-A or anti-B. upper left panel reacted with anti- B but not anti-A, those in the lower right panel reacted with anti-A but not anti-B upper right panel contains cells that react with both anti-A and anti-B Four subpopulations can be distinguished:
  • 78.
    • Leukemia isthe unchecked proliferation of an abnormal clone of hematopoietic cells • The diagnosis of leukemia is made on the basis of two findings. – One is the detection of abnormal cells in the bloodstream, and the other is observation of abnormal cells in the bone marrow. • An abnormal cell displays surface immunoglobulin would be assigned to the B-cell lineage and its maturational stage would be that of a mature B cell. • On the other hand, a cell that had cytoplasmic heavy chains, but no surface immunoglobulin, would be a B-lineage leukemic cell but at the maturational stage of a pre-B cell.
  • 79.
    • Immunophenotyping usesflow cytometry and monoclonal antibodies • The availability of monoclonal antibodies specific for each of the scores of antigens found on various types and subtypes of hematopoietic cells has made it possible to identify patterns of antigen expression that are typical of – cell lineages, – maturational stages, and – a number of different types of leukemia
  • 81.
    Application • Most cancercenters are equipped with flow cytometers that are capable of performing and interpreting the multiparameter analyses necessary to provide useful profiles of surface markers on tumor cell populations. • Flow cytometric determination of immuno-phenotypes allows: – Confirmation of diagnosis – Diagnosis when no clear judgment can be made based on morphology or patterns of cytochemical staining – Identification of aberrant antigen profiles that can help identify the return of leukemia during remission – Improved prediction of the course of the disease
  • 83.
    SUMMARY • Antigen-antibody interactionsdepend on four types of noncovalent interactions: hydrogen bonds, ionic bonds, hydrophobic interactions, and van der Waals interactions. • The affinity constant, which can be determined by Scatchard analysis, provides a quantitative measure of the strength of the interaction between an epitope of the antigen and a single binding site of an antibody. • The avidity reflects the overall strength of the interactions between a multivalent antibody molecule and a multivalent antigen molecule at multiple sites. • The interaction of a soluble antigen and precipitating antibody in a liquid or gel medium forms an Ag-Ab precipitate. • Electrophoresis can be combined with precipitation in gels in a technique called immunoelectrophoresis.
  • 84.
    • The interactionbetween a particulate antigen and agglutinating antibody (agglutinin) produces visible clumping, or agglutination that forms the basis of simple, rapid, and sensitive immunoassays. • The enzyme-linked immunosorbent assay (ELISA) depends on an enzyme-substrate reaction that generates a colored reaction product. • ELISA assays that employ chemiluminescence are the most sensitive immunoassays available. • In Western blotting, a protein mixture is separated by electrophoresis; then the protein bands are electrophoretically transferred onto nitrocellulose and identified with labeled antibody or labeled antigen. • Fluorescence microscopy using antibodies labeled with fluorescent molecules can be used to visualize antigen on or within cells. • Flow cytometry provides an unusually powerful technology for the quantitative analysis and sorting of cell populations labeled with one or more fluorescent antibodies.
  • 85.
    Hemeagglutination • Agglutination reactionsare routinely performed to type red blood cells • In typing for the ABO antigens, RBCs are mixed on a slide with antisera to the A or B blood-group antigens. • If the antigen is present on the cells, they agglutinate, forming a visible clump on the slide. • Determination of which antigens are present on donor and recipient RBCs is the basis for matching blood types for transfusions.
  • 86.
    1. Cross-Reactivity • Insome cases antibody elicited by one antigen can cross-react with an unrelated antigen. • Cross-reactivity occurs if two different antigens share an identical or very similar epitope • Cross-reactivity is often observed among polysaccharide antigens that contain similar oligosaccharide residues.
  • 87.
    Example:  The ABOblood-group antigens, for example, are glycoproteins expressed on red blood cells.  Cross-reactivity is often observed among polysaccharide antigens that contain similar oligosaccharide residues.
  • 88.
    • Type Aindividual has anti-B antibodies; • Type B individual has anti-A; • Type O individual has anti-A and anti-B
  • 89.
    • Antibodies areproduced to these antigens • The antibodies are induced not by exposure to red blood cell antigens but by exposure to cross-reacting microbial antigens present on common intestinal bacteria. • These microbial antigens induce the formation of antibodies in individuals lacking the similar blood-group antigens on their red blood cells • These blood-group antibodies, although elicited by microbial antigens, will cross-react with similar oligosaccharides on foreign red blood cells, • This provides the basis for blood typing tests and accounting for the necessity of compatible blood types during blood transfusions.
  • 90.